Composition
- Active substance
- milnacipran
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Impulsor
- Active substance
- milnacipran
- Therapeutic area
- Fibromyalgia
- Marketing authorisation holder
- Pierre Fabre Medicament
- Status
- Refused
- Refused
- 8 Apr 2010
- EMA product number
- EMEA/H/C/001122
EMA designations
- Orphan medicine
- No
- Conditional approval
- No
- Biosimilar
- No
- Generic
- No
- Accelerated assessment
- No
- Additional monitoring
- No
- Patient safety information
- No